Company Information
Company Introduction
Time: 2026-04-14 16:41:31
Click:
On April 10, 2026, the 26th International Congress of Ophthalmology (COOC 2026) officially kicked off at the Shanghai Convention & Exhibition Center of International Sourcing. Staying true to its core mission of 'serving clinical practice,' this year's congress focuses on life-course eye health, smart ophthalmology, and clinical innovation, building a high-end platform for cutting-edge academic exchange and technological achievement display in ophthalmology and optometry. As a flagship annual event in Chinese ophthalmology, the congress brings together leading ophthalmology experts, clinicians, and industry elites from home and abroad to explore academic frontiers and innovative paths for diagnosis and treatment. HWBIO, an innovative enterprise in the dry eye treatment field, showcased its core product — the MeiboRevive™ Vectored Thermal Pulsation System — making a major impact at the exhibition with its leading technology and professional services, becoming one of the most visited booths.

Flagship Product Makes a Powerful Debut, Precisely Addressing Dry Eye Clinical Pain Points
On the first day of the exhibition, HWBIO's booth drew significant attention. Its self-developed MeiboRevive™ Vectored Thermal Pulsation System, with its core technological advantages, attracted numerous ophthalmology experts, clinicians, and industry partners for in-depth consultation and exchange. This device is the flagship achievement of HWBIO's deep cultivation in the dry eye field. Leveraging its proprietary vectored thermal pulsation core technology, it precisely targets dry eye disease caused by meibomian gland dysfunction (MGD). Adopting a synergistic treatment model of 'precise heating + pulsed massage,' the device uses temperature control technology to deliver constant heating to the meibomian gland area, softening obstructed lipids, and then applies rhythmic pulsed massage to unblock the meibomian glands, effectively addressing the root cause of dry eye. It provides a safe, efficient, and standardized clinical solution for dry eye, closely meeting real clinical needs.

Immersive Experience Zone Draws Enthusiastic Response, 3D Interaction Demonstrates Technological Strength
To help attendees experience the product's value more intuitively, HWBIO specially created an exclusive experience zone for the MeiboRevive™ Vectored Thermal Pulsation System, featuring an innovative three-dimensional interactive model combining 'technical explanation, live demonstration, and hands-on experience.' A senior technical team was on hand throughout to explain the device's technical principles, clinical application advantages, applicable scenarios, and operating procedures in detail. Many physicians who tried the device gave high praise, noting that it is easy to operate, comfortable for patients, and offers significant therapeutic effects, effectively addressing clinical pain points in dry eye management, improving treatment efficiency and patient satisfaction. The on-site consultation and discussion atmosphere was extremely lively.

Deepening Commitment to Dry Eye Treatment, Protecting National Eye Health through Innovation
This appearance at COOC 2026 is not only a concentrated showcase of HWBIO's core technology and product strength but also an important opportunity to connect with clinical needs and promote industry-academia-research translation. As an innovative enterprise focused on high-end ophthalmic medical devices, HWBIO has always been guided by clinical needs, continuously deepening its work in the dry eye treatment field. Relying on independent R&D and technological innovation, the company constantly iterates and optimizes its product portfolio. Looking ahead, HWBIO will continue to advance in the ophthalmic medical field, following the COOC congress's direction of 'serving clinical practice and leading with scholarship,' deepening technological R&D and clinical application, helping to comprehensively upgrade dry eye diagnosis and treatment, and contributing professional strength to safeguarding the life-course eye health of the nation.